• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    NF-KB
    January 29, 2020
    DIGITALIS PURPUREA (DIGOXIN)
    January 29, 2020
    1. Pseudo-aldosteronism induced by intravenous Glycyrrhizin treatment of chronic hepatitis C patients
    2. … -performance liquid chromatographic determination of puerarin, daidzin, paeoniflorin, liquiritin, cinnamic acid, cinnamaldehyde and Glycyrrhizin in Kampo medicines
    3. … . ex DC. containing high concentrations of Glycyrrhizin by Eastern blotting and enzyme-linked immunosorbent assay using anti-Glycyrrhizin monoclonal antibody for …
    4. … after Total Adrenalectomy: II. Levels of 17-Ketosteroids and Formaldehy-Dogenic Substances in Patients on Varying Dosages of Cortisone Acetate and Glycyrrhizin
    5. … box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model and Parkinson’s disease which can be attenuated by Glycyrrhizin
    6. … C virus (CH-C) in India: a randomized controlled trial comparing daily interferon-alfa-2b and ribavirin with daily interferon-alfa-2b and Glycyrrhizin—a multicenter study
    7. … crude drugs. IV. Quantitative analysis of constituents in the crude drugs by rod-thin-layer chromatography with FID.(1). Determination of Glycyrrhizin in liquorice roots …
    8. … effects, immune regulatory actions, and inhibition of hepatic apoptosis, necrosis and antitumor effects [17]. In addition, Glycyrrhizin and 18β-glycyrrhetinic acid …
    9. … MULTICOMPONENT MEDICAL COMPOSITION WITH IMMUNOSTIMULATIVE AND ANTIOXIDANT ACTIVITIES (Glycyrrhizin ACID, KHITOZAN, ZEOLITE …
    10. … natural population accessions of Glycyrrhiza glabra L.(Fabaceae) in central Zagros region of Iran, based on quantitative morphology, flavonoids and Glycyrrhizin …
    11. … natural population accessions of Glycyrrhiza glabra L.(Fabaceae) in central Zagros region of Iran, based on quantitative morphology, flavonoids and Glycyrrhizin …
    12. … notably the 3-O-glycosides abrusosides A–D (C6| C6| C6| C5CH (CH) C5L 3-O-glycosides) from Abrus species (Fabaceae) and Glycyrrhizin (glycyrrhizic acid) from …
    13. … of double eastern blotting for major licorice components, Glycyrrhizin and liquiritin for chemical quality control of licorice using anti-Glycyrrhizin and anti-liquiritin …
    14. … of Glycyrrhizin and liquiritin in licorice roots and Kampo medicines by combination enzyme-linked immunosorbent assay using anti-Glycyrrhizin and anti-liquiritin …
    15. … of Glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing Glycyrrhizin and related compounds
    16. … on effects of Achyranthes bidentata on tongsaimai pellets main active ingredients chlorogenic acid, isoliquiritin, harpagoside and Glycyrrhizin in vivo pharmacokinetics
    17. … on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of Glycyrrhizin
    18. … on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine” kampoo”. Iii. Precipitation reaction of Glycyrrhizin with alkaloids or …
    19. … on the pharmaceutical quality evaluation of crude drug preparations used in orient medicine” Kampoo”. III. Precipitation reaction of Glycyrrhizin with alkaloids or …
    20. … profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either Glycyrrhizin, silibinin or spironolactone in rat
    21. … Quality Evaluation of Crude Drug Preparations used in Orient Medicine” Kampoo”. II. Precipitation Reaction of Berberine and Glycyrrhizin in Aqueous Solution
    22. … quality evaluation of crude drug preparations used in orient medicine” kampoo”. II. Precipitation reaction of berberine and Glycyrrhizin in aqueous solution.
    23. … Reaction between Berberine and Glycyrrhizin in Decoctions of Natural Medicines: Interaction Studies of Cyclodextrins with Glycyrrhizin and Glycyrrhetic Acid by 1H …
    24. … ribosomal P proteins from porcine liver and the inhibition of their immunocomplex formation with sera from systemic lupus erythematosus (SLE) patients by Glycyrrhizin …
    25. 18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells
    26. 52weeks clinical observation of combination therapy of telbivudine with compound Glycyrrhizin tables on chronic hepatitis B
    27. A 96-KDa Glycyrrhizin-binding protein (gp96) from soybeans acts as a substrate for case in kinase II, and is highly realted to lipoxygenase3
    28. A case of Glycyrrhizin (licorice)-induced hypokalemic myopathy
    29. A case of pseudoaldosteronism induced by Glycyrrhizin
    30. A Case of Pseudoaldosteronism with Muscle Weakness due to Oral Glycyrrhizin
    31. A clinical observation of compound Glycyrrhizin injection in treatment of 40 children with henoch-schonlein purpura
    32. A clinical study on treatment of chromic hepatitis B with acute exacerbation by Compound Glycyrrhizin Injection [J]
    33. A comparative study of Glycyrrhizin and glycyrrhetinic acid complexes interactions with DNA and RNA
    34. A comparison of the antihepatotoxic activity between Glycyrrhizin and glycyrrhetinic acid
    35. A Comprison of Cost-effectiveness Between Compound Glycyrrhizin and Interferon α-1b in Treating Chronic Hepatitis B
    36. A discovery of Glycyrrhizin synthase in a medical plant, liquorice [Glycyrrhiza uralensis].
    37. A first report of porphyria cutanea tarda successfully treated with Glycyrrhizin
    38. A Glycyrrhizin‐containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice
    39. A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and Glycyrrhizin in a Chinese proprietary medicine
    40. A highly sensitive LC–MS/MS method for simultaneous determination of Glycyrrhizin and its active metabolite glycyrrhetinic acid: Application to a human …
    41. A long-term Glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of …
    42. A Membrane-Based Process for the Recovery of Glycyrrhizin and Phenolic Compounds from Licorice Wastewaters
    43. A new anti-human immunodeficiency virus substance, Glycyrrhizin sulfate; endowment of Glycyrrhizin with reverse transcriptase-inhibitory activity by chemical …
    44. A novel glucuronosyltransferase has an unprecedented ability to catalyse continuous two‐step glucuronosylation of glycyrrhetinic acid to yield Glycyrrhizin
    45. A novel preparation of concentrated Glycyrrhizin solution by pretreatment with eugenol
    46. A novel serum-stable liver targeted cytotoxic system using valerate-conjugated chitosan nanoparticles surface decorated with Glycyrrhizin
    47. A novel β-glucuronidase from Talaromyces pinophilus Li-93 precisely hydrolyzes Glycyrrhizin into glycyrrhetinic acid 3-O-mono-β-d-glucuronide
    48. A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl’s melanosis
    49. A possible involvement of 3-monoglucuronyl-glycyrrhetinic acid, a metabolite of Glycyrrhizin (GL), in GL-induced pseudoaldosteronism
    50. A randomized controlled trial comparing total glucosides of paeony capsule and compound Glycyrrhizin tablet for alopecia areata
    51. A randomized controlled trial of Glycyrrhizin plus tenofovir vs. tenofovir in chronic hepatitis B with severe acute exacerbation
    52. A Research on Seasonal Dynamics of Biomass of Glycyrrhizin Uralensis Seedings in Western Part of Jilin Province [J]
    53. A Review on the Role of Nutraceuticals as Simple as Se2+ to Complex Organic Molecules Such as Glycyrrhizin That Prevent as Well as Cure Diseases
    54. A semi-physiologically based pharmacokinetic pharmacodynamic model for Glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit …
    55. A simple preparation method for dispersing Glycyrrhizin solution into oil phase using an evaporation technique
    56. A Simple Semi‐preparative Reversed‐phase HPLC/PDA Method for Separation and Quantification of Glycyrrhizin in Nine Samples of Glycyrrhiza glabra Root …
    57. A study on the pharmacetical characteristics & analysis of Glycyrrhizin extract
    58. A Study to Investigate the Cytotoxic role of Glycyrrhizin A Triterpenoid Glycoside from Glycyrrhiza Glabra in Cervical Cancer
    59. A systematic review of quality of randomized controlled trials of Glycyrrhizin acid to treat hepatitis in China
    60. Absorption-enhancing effect of Glycyrrhizin induced in the presence of capric acid
    61. Acetyl glycyrrhetinic acid methyl ester as a promising Glycyrrhizin derivative against the breast cancer cells (MCF-7)
    62. Administration-route dependency of absorption of Glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability
    63. Adsorption separation of 3β-D-monoglucuronyl-18βglycyrrhetinic acid from directional biotransformation products of Glycyrrhizin
    64. Advances in studies on Glycyrrhizin [J]
    65. Affection of Glycyrrhizin on Expression of CCL20 in HepG2. 2. 15 Cells [J]
    66. Agrobacterium rhizogenes induced hairy root development and its effect on production of Glycyrrhizin in Abrus precatorius (L)
    67. Alleviation of salt stress and changes in Glycyrrhizin accumulation by arbuscular mycorrhiza in liquorice (Glycyrrhiza glabra) grown under salinity stress
    68. Ameliorative effects of Glycyrrhizin on streptozotocin‐induced diabetes in rats
    69. AMMONIACAL COMPOUND OF Glycyrrhizin.
    70. Ammonium Glycyrrhizin counteracts liver injury caused by lipopolysaccharide/amoxicillin-clavulanate potassium
    71. An antigranulomatous effect of Glycyrrhizin
    72. An antigranulomatous effect of Glycyrrhizin.
    73. An Approach to Treatment of Liver Cancer by Novel Glycyrrhizin Derivative
    74. An Artificial Sweetener Stimulates the Sweet Taste in Insect: Dual Effects of Glycyrrhizin in Phormia regina
    75. An experimental studies on the growth inhibition and its action of a salivary gland tumor by Glycyrrhizin
    76. An inhibitory effect of Glycyrrhizin on metabolic actions of cortisone
    77. An Observation on Curative Effects of Compound Glycyrrhizin in the Treatment of Chronic Type B Hepatitis with Hepatic Fibrosis
    78. An on-membrane quantitative analysis system for Glycyrrhizin in licorice roots and traditional Chinese medicines
    79. AN OVERVIEW ON THE EXTRACTION, SEPARATION, AND APPLICATIONS OF Glycyrrhizin AND GLYCYRRHETIN [J]
    80. Analysis of broad-sense heritability and genetic correlation of production and content of Glycyrrhizin of annual Glycyrrhiza uralensis
    81. Analysis of Clinical Effects of Compound Glycyrrhizin and Levocetirizine on Treating Chronic Eczema
    82. Analysis of clinical effects of Compound Glycyrrhizin on treatment of 53 cases of psoriasis vulgaris.
    83. Analysis of content differences and variation trends of the principal component isomers and related substances in the four generations of Glycyrrhizin preparations
    84. Analysis of the Chest X-ray Manifestations in SARS Patients Treated with Compound Glycyrrhizin
    85. Analysis of the Chest X-ray Manifestations in SARS Patients Treated with Compound Glycyrrhizin [J]
    86. Analysis of the synergistic effect of Glycyrrhizin and other constituents in licorice extract on lipopolysaccharide-induced nitric oxide production using knock-out extract
    87. Analysis of therapeutic efficacy of the combination of 308 nm excimer laser with compound Glycyrrhizin for treatment of vitiligo
    88. Anaphylactic shock and ventricular extrasystole following an IV infusion of compound Glycyrrhizin in a patient with allergic dermatitis [J]
    89. Anti-inflammative effect of Glycyrrhizin on rat thermal injury via inhibition of high-mobility group box 1 protein
    90. Anti-inflammatory effects of intramammary infusions of Glycyrrhizin in lactating cows with mastitis caused by coagulase-negative staphylococci
    91. Anti-liver Fibrosis Effect of Ganlong Capsule Combined with Compound Glycyrrhizin Glucoside
    92. Anti-obesity effect of Chitosan-Glycyrrhizin conjugate
    93. Anti-obesity effect of Glycyrrhizin on obese rats and its mechanism [J]
    94. Anti-Proliferative and Differentiation-Inducing Effects of Glycyrrhizin and 18p-Glycyrrhetinic Acid on Neuroblastoma Cells In Vitro
    95. Anti-tumor Activity of Adriamycin-loaded Chitosan Nanoparticles Surface-modified with Glycyrrhizin on Human Hepatoma Cell Line SMMC-7721
    96. Antidiabetic effect of Glycyrrhizin in genetically diabetic KK-Ay mice
    97. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, Glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction
    98. Antifibrotic effects of Glycyrrhizin and matrine in vitro and in vivo
    99. Antifibrotic Effects of High-Mobility Group Box 1 Protein Inhibitor (Glycyrrhizin) on Keloid Fibroblasts and Keloid Spheroids through Reduction of Autophagy …
    100. Antihyperglycemic effect of 18β-glycyrrhetinic acid, aglycone of Glycyrrhizin, on streptozotocin-diabetic rats
    101. Antioxidant activities of Glycyrrhizin and its effect on renal expression of Na, K-ATPase in gentamicin-induced acute renal failure rats
    102. Antioxidant and DNA protective effects of NTX, a proprietary Glycyrrhizin/d-mannitol product, in association with alcohol consumption: A randomized, placebo …
    103. Antioxidant status and immune activity of Glycyrrhizin in allergic rhinitis mice
    104. ANTISTRESS POTENTIAL OF Glycyrrhizin IN FORCED SWIM STRESS
    105. Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor
    106. Antiviral activities of Glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro
    107. Antiviral activities of Glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro.
    108. Antiviral activity of Glycyrrhizin against hepatitis C virus in vitro
    109. Antiviral activity of Glycyrrhizin against varicella-zoster virus in vitro
    110. Antiviral and immune stimulant activities of Glycyrrhizin against duck hepatitis virus
    111. Antiviral Effect of Glycyrrhizin on Porcine Respiratory Coronavirus (PRCV).
    112. Antiviral effects of the combination of Glycyrrhizin and ribavirin against influenza a H1N1 virus infection in vivo
    113. Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and Glycyrrhizin-mediated inhibition
    114. Application of an amine functionalized biopolymer in the colonic delivery of Glycyrrhizin: a design and in vivo efficacy study
    115. Application of Glycyrrhizin in the preparation of medicine for preventing and curing tumour
    116. Application of ion-pair high-performance liquid chromatography to the analysis of Glycyrrhizin in Glycyrrhizae radix
    117. Application of liquid particle extraction to the purification of Glycyrrhizin
    118. Application of pressure‐controlled colon delivery capsule to oral administration of Glycyrrhizin in dogs
    119. Approach to enhancing the distribution of Glycyrrhizin in the liver: intravenous infusion studies in a rat model of bile duct ligation
    120. Arabinogalactan and Glycyrrhizin based nanopesticides as novel delivery systems for plant protection
    121. Arbuscular mycorrhiza facilitates the accumulation of Glycyrrhizin and liquiritin in Glycyrrhiza uralensis under drought stress
    122. Assessment of circulating biochemical markers in mice receiving cinnamon and Glycyrrhizin under carbon tetrachloride induced hepatic injury
    123. Assessment of the tolerability profile of an ophthalmic solution of 5% Glycyrrhizin and copolymer PEG/PPG on healthy volunteers and evaluation of its efficacy …
    124. Attenuation of dysfunction in the ischemia-reperfused liver by Glycyrrhizin
    125. Augmented antiproliferative effect of tumor necrosis factor (TNF), lymphotoxin and Glycyrrhizin in combined use with diethyldithiocarbamate on Meth A tumor cells in …
    126. Bidirectional control by Glycyrrhizin of the growth response of lymphocytes stimulated through a receptor-bypassed pathway
    127. Biliary excretion and enterohepatic cycling of Glycyrrhizin in rats
    128. Biliary excretion of Glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions
    129. Bimodal effect of Glycyrrhizin on macrophage nitric oxide and prostaglandin E2 production
    130. Binding of Glycyrrhizin to human serum and human serum albumin
    131. Binding of Glycyrrhizin to rat plasma and rat serum albumin
    132. Bioavailability of Glycyrrhizin and licorice extract in rat and human plasma as detected by a HPLC method.
    133. Bioavailability of Glycyrrhizin from Shaoyao‐Gancao‐Tang in laxative‐treated rats
    134. Bioavailability study of glycyrrhetic acid after oral administration of Glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis
    135. Biocatalytic properties of a novel crude Glycyrrhizin hydrolase from the liver of the domestic duck
    136. Biochemical and histological effects of 26 weeks of Glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial
    137. Biochemical characterization of bovine lactoferrin as a Glycyrrhizin-binding protein in vitro
    138. Biochemical characterization of Glycyrrhizin as an effective inhibitor for hyaluronidases from bovine testis
    139. Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a Glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity …
    140. Biochemical characterization of selective inhibitors for a Glycyrrhizin-binding lipoxygenase from soybeans
    141. Bioequivalence of domestic and imported compound Glycyrrhizin tablets in Chinese healthy male volunteers
    142. Bioequivalence of Glycyrrhizin capsules by HPLC-MS [J]
    143. Bioequivalence research of Compound Glycyrrhizin capsules
    144. Bioinformatics Study and Investigation of the Expression Pattern of Several Important Genes Involved in Glycyrrhizin Synthesis of Glycyrrhiza glabra L. in Autumn and …
    145. Biotechnological aspects of the production of natural sweetener Glycyrrhizin from Glycyrrhiza sp.
    146. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, Glycyrrhizin, and baicalin by human fecal …
    147. Biotransformation of Glycyrrhizin by Aspergillus niger
    148. Biotransformation of Glycyrrhizin by buffered cell suspension cultures of Catharanthus roseus
    149. Biotransformation of Glycyrrhizin by Buffered Cell Suspension Cultures of Catharanthus roseus.
    150. Biotransformation of Glycyrrhizin by human intestinal bacteria and its relation to biological activities
    151. Biotransformation of Glycyrrhizin to 18β-glycyrrhetinic acid-3-O-β-D-glucuronide by Streptococcus LJ-22, a human intestinal bacterium
    152. Blocking effects of blended paeoniflorin or its related compounds with Glycyrrhizin on neuromuscular junctions in frog and mouse
    153. Butyl Flufenamate Ointment and Abcompound Glycyrrhizin Tabletin the Treatment of Postherpetic Neuralgia
    154. Can active components of licorice, Glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?
    155. Candesartan and Glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade
    156. CD34+ CD31+ immature myeloid cells (IMC) as an inhibitor cell on the production of antimicrobial peptide: III. Translational studies of Glycyrrhizin in humanized NOD …
    157. Changes in components, Glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions
    158. Changes in Glycyrrhizin content of Iranian licorice (Glycyrrhiza glabra L.) affected by different root diameter and ecological conditions
    159. Characteristics and molecular determinants of a highly selective and efficient Glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10
    160. Characteristics of intestinal absorption and disposition of Glycyrrhizin in mice
    161. Characterization of an apoptosis-inducing factor in Habu snake venom as a Glycyrrhizin (GL)-binding protein potently inhibited by GL in vitro
    162. Characterization of bovine and human lactoferrins as Glycyrrhizin-binding proteins and their phosphorylation in vitro by casein kinase II
    163. Characterization of bovine angiogenin-1 and lactogenin-like protein as Glycyrrhizin-binding proteins and their in vitro phosphorylation by C-kinase
    164. Characterization of complement C3 as a Glycyrrhizin (GL)-binding protein and the phosphorylation of C3α by CK-2, which is potently inhibited by GL and glycyrrhetinic …
    165. Characterization of Glycyrrhizin-binding protein kinase from the crude membrane fraction of rat liver
    166. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a Glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated …
    167. Characterization of the interaction of Glycyrrhizin and glycyrrhetinic acid with bovine serum albumin by spectrophotometric-gradient flow injection titration technique …
    168. Characterization of three ocular clinical isolates of P. aeruginosa: viability, biofilm formation, adherence, infectivity, and effects of Glycyrrhizin
    169. Chemical assay of Glycyrrhizin in medicinal plants by pressurized liquid extraction (PLE) with capillary zone electrophoresis (CZE)
    170. Chemopreventive activity of Glycyrrhizin on lead acetate mediated hepatic oxidative stress and its hyperproliferative activity in Wistar rats
    171. Chronic effects of ginseng saponin, Glycyrrhizin and flavin adenine dinucleotide on adrenal and thymus weight in normal and dexamethasone-treated rats
    172. Cilostazol/Glycyrrhizin interaction
    173. Clinic Observation on Compound Glycyrrhizin Injection Treatment for Children with Henoch-Schonlein Purpura [J]
    174. Clinical Analysis of Compound Glycyrrhizin Injection Combined with Acitretin in the Treatment of Erythrodermic Psoriasis [J]
    175. Clinical analysis of compound Glycyrrhizin tablets combined with tretinoin cream and mometasone furoate cream in treating psoriasis vulgaris
    176. Clinical analysis of the function of Salvia Miltiorrhiza combined with Comp-ound Glycyrrhizin Injection (Stronger Neo-Minophagen C) in the treatment of alcoholic liver …
    177. Clinical Analysis of Treatment on Generalized Pustular Psoriasis through Compound Glycyrrhizin in Combination with Acitretin
    178. Clinical and experimental study on treatment of atopic dermatitis with Glycyrrhizin
    179. CLINICAL AND LABORATORY OBSERVATION ON THE EFFECT OF Glycyrrhizin IN ACUTE AND CHRONIC VIRAL HEPATITIS
    180. Clinical Application of Compound Glycyrrhizin Glucoside in Dermatology (Review)[J]
    181. Clinical Application of Compound Glycyrrhizin Glucoside in Dermatology [J]
    182. Clinical Application of Glycyrrhizin and Its Pharmacological Effect
    183. Clinical characteristics of five elderly patients with severe hypokalemia induced by Glycyrrhizin derivatives
    184. Clinical effect comparison between compound Glycyrrhizin injection and diammonium Glycyrrhizinate injection in treatment of extensive eczema
    185. Clinical Effect Observation of Compound Glycyrrhizin Combined Tripterygium Glycosides in Treatment of Palmoplantar Pustulosis [J]
    186. Clinical effect observation of compound Glycyrrhizin on the prevention and cure of cytarabine syndromes
    187. Clinical Effect of Compound Glycyrrhizin Injection in Treatment of Acute Urticaria
    188. Clinical Effect of Mizolastine Combined with Compound Glycyrrhizin Capsules in the Treatment of Chronic Urticaria
    189. Clinical effects of compound Glycyrrhizin combined with glutathione for 60 cases with alcoholic liver disease [J]
    190. Clinical Effects of Compound Glycyrrhizin Injection, Tacrolimus Ointment, Avene on Facial Corticosteroid Addictive Dermatitis [J]
    191. Clinical efficacy and IgE levels of ebastine joint Compound Glycyrrhizin on acute and chronic urti-caria patients
    192. Clinical Efficacy Observation of Compound Glycyrrhizin Combined with Triamcinolone Acetonide in the Treatment of Oral Lichen Planus
    193. Clinical efficacy of combination of vidarabine monophosphate with compound Glycyrrhizin in treatment of herpes zoster.
    194. CLINICAL EFFICACY OF COMPOUND Glycyrrhizin COMBINED WITH ACITRETIN FOR GENERALIZED PUSTULAR PSORIASIS [J]
    195. Clinical Efficacy of Compound Glycyrrhizin Combined with Famciclovir for Herpes Zoster [J]
    196. Clinical Efficacy of Compound Glycyrrhizin Combined with Reduced Glutathione on Patients with Alcoholic Liver Cirrhosis [J]
    197. Clinical Efficacy of Epinastine in Combination with Compound Glycyrrhizin for Chronic Eczema [J]
    198. Clinical efficacy study of polyene phosphatidylcholine combined with compound Glycyrrhizin in treatment of non-alcoholic fatty liver
    199. Clinical evaluation of compound Glycyrrhizin for treatment of antituberculous drug-induced liver disease [J]
    200. Clinical investigation of compound Glycyrrhizin combined with bozhi glycopeptide in treatment of erythema nodosum
    201. Clinical Investigation of Compound Glycyrrhizin with Adefovir Dipivoxil in the treatment of Hepatic Fibrosis of Chronic Hepatitis B
    202. Clinical Investigation on Glycyrrhizin Compound with Rifampicin and Doxycycline in Treating Brucellosis
    203. Clinical Investigation on the Efficacy of Facial Mask Combined Triclosan with Glycyrrhizin for Acne Vulgaris
    204. Clinical observation and pharmacoeconomic evaluation on compound Glycyrrhizin in the treatment of psoriasis vulgaris [J]
    205. Clinical observation of Compound Glycyrrhizin and Oxymatrine in the treatment of 52 cases with chronic hepatitis B
    206. Clinical Observation of Compound Glycyrrhizin Combination with Acyclovir in the Treatment of Children with Infectious Mononucleosis
    207. Clinical Observation of Compound Glycyrrhizin Combining Flumetasone in the Treatment of Chronic Eczema [J]
    208. Clinical observation of compound Glycyrrhizin for Non-Alcoholic steatohepatitis
    209. Clinical Observation of Compound Glycyrrhizin Injection on Treatment of Pollinosis
    210. Clinical observation of compound Glycyrrhizin on chronic hepatitis B [J]
    211. Clinical observation of compound Glycyrrhizin on hepatic fibrosis of chronic hepatitis B [J]
    212. Clinical Observation of Glycyrrhizin Decremental Treatment Combined with Ebastine for Chronic Urticaria [J]
    213. Clinical Observation of Runzaozhiyang Capsules Combined with Compound Glycyrrhizin in the Treatment of Xiexvfengzao Eczema
    214. CLINICAL OBSERVATION OF THE EFFICACY OF Glycyrrhizin IN THE TREATMENT OF NEWBORNS WITH HYPERBILIRUBINAEMIA [J]
    215. Clinical Observation of Therapeutic Effect of Compound Glycyrrhizin on SARS
    216. Clinical Observation of Therapeutic Effect of Compound Glycyrrhizin on SARS [J]
    217. Clinical Observation on Compound Glycyrrhizin Combined with Interferon α-2b in the Treatment of Chronic Hepatitis B
    218. Clinical Observation on Compound Glycyrrhizin Combined with Interferon?-2b in the Treatment of Chronic Hepatitis B
    219. Clinical observation on compound Glycyrrhizin combined with narrow-band UVB in treatment ofpsoriasis vulgaris [J]
    220. Clinical Observation on Compound Glycyrrhizin in Combination with Acyclovir for Herpes Zoster [J]
    221. Clinical Observation on Compound Glycyrrhizin Injection Combined with Alprostadil Injection for Severe Cholestatic Virus Hepatitis [J]
    222. Clinical Observation on Glycyrrhizin Anhydride in the Treatment of Drug-induced Liver Damage
    223. Clinical Observation on the Clinical Efficacy of Compound Glycyrrhizin in the Antitubercuolsis Treatment of Chronic Hepatitis B [J]
    224. Clinical observation on the clinical efficacy of compound Glycyrrhizin in the treatment of new pulmonary tuberculosis complicated with chronic hepatitis B
    225. Clinical observation on the clinical efficacy of Compound Glycyrrhizin in the treatment of tuberculosis with retreated and chronic hepatitis B (Analysis of 56 cases)
    226. Clinical Observation on Therapeutic Effect of Compound Glycyrrhizin for Facial Hormone Dependence Dermatitis [J]
    227. Clinical observation on treatment of primary Sjögren’s syndrome by compound Glycyrrhizin injection
    228. Clinical observations and influence on NO of compound Glycyrrhizin on cirrhotic patients following chronic hepatitis B
    229. Clinical Research of Compound Glycyrrhizin Combined with Large Dose Hepatocyte Growth-promoting Factors in the Treatment of Severe Hepatitis [J]
    230. Clinical Research of Compound Glycyrrhizin Combined with Levofloxacin and Doxycycline in the Treatment of Chronic Brucellosis
    231. Clinical Research of Entecavir Combined with Compound Glycyrrhizin Tablets on Chronic Hepatitis B with HBeAg-Positive [J]
    232. Clinical spectrum of acute sporadic hepatitis E and possible benefit of Glycyrrhizin therapy
    233. Clinical study of Glycyrrhizin in combination with lamivudine for treatment of HBV-related nephritis
    234. Clinical Study of Hyperbaric Oxygen Combined with Compound Glycyrrhizin in the Treatment of Psoriasis Vulgaris
    235. Clinical study of PHGF combined with compound Glycyrrhizin on patients with severe hepatitis
    236. Clinical Study on the Prevention of Glycyrrhizin on the Hepatitis Resulted from Antituberculous Drugs [J]
    237. Clinical study on treatment of severe viral hepatitis by Compound Glycyrrhizin Injection [J]
    238. Clinical Therapeutic Observation of Man’gan Decoction Plus Compound Glycyrrhizin in the Treatment of Chronic Type B Hepatitis
    239. Clinical trial of compound Glycyrrhizin injection for the treatment of radiation-induced liver disease [J]
    240. Cloning and characterization of a cDNA encoding β-amyrin synthase involved in Glycyrrhizin and soyasaponin biosyntheses in licorice
    241. Clostridium Glycyrrhizinilyticum Sp. Nov., a Glycyrrhizin‐Hydrolysing Bacterium Isolated from Human Faeces
    242. Clove oil prevents Glycyrrhizin gel formation in aqueous solution
    243. Co-delivery of Glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for …
    244. COLORIMETRIC DETERMINATION OF Glycyrrhizin CONTENT IN THE CRUDE AND HONEY-PROCESSED GLYCYRRHIZA WITH VANILLIN-SULPHURIC ACID …
    245. Colorimetric Estimation of Glycyrrhizin Content in Glycyrrhizainflata Produced in Four Provinces [J]
    246. Combination of Spirulina with Glycyrrhizin prevents cognitive dysfunction in aged obese rats
    247. Combination therapy of Glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
    248. Combination therapy of orally administered Glycyrrhizin and UVB improved active-stage generalized vitiligo
    249. Combination therapy with salicylic acid chemical peels, Glycyrrhizin compound, and vitamin C for Riehl’s melanosis
    250. Combined ursodeoxycholic acid and Glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
    251. Combining compound Glycyrrhizin with hepatocyte growth-promoting factors for treatment of hepatic fibrosis [J]
    252. Comparative analysis of the effect of Glycyrrhizin diammonium and lithium chloride on infectious bronchitis virus infection in vitro
    253. Comparative Studies of Different Immobilization Techniques for Conversion of Glycyrrhizin by Aspergillus niger NRRL 595
    254. Comparative study for pharmaceutical quality among bland-name drug and generic drugs of compound Glycyrrhizin injections in China
    255. Comparative study of selective in vitro and in silico BACE1 inhibitory potential of Glycyrrhizin together with its metabolites, 18α-and 18β-glycyrrhetinic acid, isolated …
    256. COMPARING STUDIES ON THE COMPONENTS OF Glycyrrhizin IN FIVE KINDS OF GLYCYRRHIZA UNDER THE SAME CONDITIONS [J]
    257. COMPARING STUDIES ON THE COMPONENTS Or Glycyrrhizin IN FIVE KINDS OF GLYCYRRHIZA UNDER THE SAME CONDITIONS
    258. Comparison of clinical efficacy and safety of triclosan lasatopine combined with compound Glycyrrhizin tablets in the treatment of chronic urticaria
    259. Comparison of Efficacies of Acyclovir with Glycyrrhizin Against Herpes Simple Virus Type 1 in Vitro
    260. Comparison of Glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan
    261. Comparison of Glycyrrhizin Contents in Granule of Dispensing Glycyrrhizae from Different Factories [J]
    262. Comparison of Particulate Contamination in Glass and Plastic Ampoules of Glycyrrhizin Injections after Ampoule Cutting.
    263. Comparison of protective effect of Glycyrrhizin drugs on human hepatocytes injured by D-galactosamine and carbon tetrachloride
    264. Comparison of the Exposure of Glycyrrhizin and its Metabolites and the Pseudoaldosteronism after Intravenous Administration of Alpha-and Beta-Glycyrrhizin in Rat
    265. Comparison of the in vitro antifibrogenic effects of silymarin, silybin a and 18α-Glycyrrhizin on activated hepatic stellate cells
    266. Comparison of Therapeutic Effects of Compound Glycyrrhizin Injection at Different Doses on Severe Hepatitis
    267. Competition in the metabolism of Glycyrrhizin with glycyrrhetic acid mono-glucuronide by mixed Eubacterium sp. GLH and Ruminococcus sp. PO1-3
    268. Complementary Effects of Paeoniflorin and Glycyrrhizin on Intracellular Call Mobilization in the Nerve-Stimulated Skeletal Muscle of Mice
    269. Compound ammonium Glycyrrhizin protects hepatocytes from injury induced by lipopolysaccharide/florfenicol through a mitochondrial pathway
    270. Compound ammonium Glycyrrhizin protects hepatocytes from injury induced by lipopolysaccharide/florfenicol through oxidative stress and a MAPK pathway
    271. Compound Flumetasone Ointment Combined with Compound Glycyrrhizin Tablets in the Treatment of Infant Eczyma in 45 Cases
    272. Compound Glycyrrhizin and Interferon in the Treatment of Chronic Hepatitis B Study [J]
    273. Compound Glycyrrhizin associated with ARA-AMP in treating chronic hepatitis B patients with YMDD Mutation
    274. Compound Glycyrrhizin Combination with Matrine Treatment for Chronic Hepatitis B
    275. Compound Glycyrrhizin Combined Montelukast Treatment of Cough Variant Asthma
    276. Compound Glycyrrhizin Combined Ornithine Aspartate Treatment of Severe Hepatitis
    277. Compound Glycyrrhizin Combined with Cetirizine in Improving the Life of Quality Patients with Chronic Urticaria [J]
    278. Compound Glycyrrhizin Combined with Mizolastine for Patients with Generalized Neurodermatitis: Observation of Curative Effects and the Influence on Psychological …
    279. Compound Glycyrrhizin Combined with Narrow Band Ultraviolet B in Treatment of Pityriasis Rosea Curative Effect
    280. Compound Glycyrrhizin for alcoholic hepatitis: observation of clinical efficacy
    281. Compound Glycyrrhizin for Chronic Hepatitis B Complicating Severe Jaundice and Hepatic Fibrosis: Observation of Clinical Efficacy [J]
    282. Compound Glycyrrhizin for Hepatic Cirrhosis Caused by Hepatitis B: Observation of Curative Efficacy [J]
    283. Compound Glycyrrhizin for Hepatic Lesion Induced by Antituberculosis Drugs: Observation of 30 Cases [J]
    284. Compound Glycyrrhizin for Pregnant Women Complicating Chronic Type B Hepatitis: Observation of Curative Effect [J]
    285. Compound Glycyrrhizin for Psoriasis Vulgaris: Observation of Curative Effects
    286. Compound Glycyrrhizin in the Prevention of Liver Injury Induced by Antituberculosis Drugs
    287. Compound Glycyrrhizin Injection treatment of children with acute jaundice hepatitis clinical observation of 35 cases
    288. Compound Glycyrrhizin Oxymatrine Joint Observation of the effect of the treatment of alcoholic cirrhosis [J]
    289. Compound Glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials
    290. Compound Glycyrrhizin plus UVB Exposure for Pityriasis Rosea
    291. Compound Glycyrrhizin tablet combined with ribavirin in treatment of eruption like papular acrodermatitis of childhood
    292. Content Determination of Glycyrrhizic Acid in Glycyrrhizin Liposome by RP-HPLC [J]
    293. Content determination of Glycyrrhizin in glycyrrhizae uralensis by dual-wavelength TLC scanning
    294. Content Determination of Paeoniflorin and Glycyrrhizin in Baihegujin Decoction with Reversed-phase High-efficiency Liquid Chromatography [J]
    295. Correction to: Comparison of Glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan
    296. Correlation between High Intake of Glycyrrhizin and Myolysis of the Papillary Muscles: An Experimental in vivo Study
    297. Counteracting effect of Glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom
    298. Critical roles of platelets in lipopolysaccharide-induced lethality: effects of Glycyrrhizin and possible strategy for acute respiratory distress syndrome
    299. Cultivation research for high-Glycyrrhizin licorice by applying low temperature and Ca2+ ion as environmental stress based on field investigation
    300. Curative Effect Observation of 30 Cases Alopecia Areata Treated by Compound Glycyrrhizin Combined PUVA [J]
    301. Curative Effect Observation on Chronic Urticaria Treated by Compound Glycyrrhizin Injection
    302. Curative Effect of Steroid-dependent Scrotitis Treated with Tacrolimus Ointment and Combine Glycyrrhizin [J]
    303. Curative Efficacy of Compound Glycyrrhizin Capsules for Chronic Hepatitis C [J]
    304. Cyclic Voltammetric Study of Complexes of Fe (III) with Saponins Isolated from Cicer aritinum and Glycyrrhizin
    305. Decreasing effects by Glycyrrhizin and paeoniflorin on intracellular Ca2+-aequorin luminescence transients with or without caffeine in directly stimulated-diaphragm …
    306. Depolarizing effects of Glycyrrhizin-derivatives relating to the blend effects with paeoniflorin in mouse diaphragm muscle
    307. Depolarizing neuromuscular blocking action induced by electropharmacological coupling in the combined effect of paeoniflorin and Glycyrrhizin
    308. Derivatization, molecular docking and in vitro acetylcholinesterase inhibitory activity of Glycyrrhizin as a selective anti-Alzheimer agent
    309. Desoxycorticosterone-mimetic action of ammoniated Glycyrrhizin in rats
    310. Determination of 18α-Glycyrrhizin and 18β-Glycyrrhizin in dog plasma by high-performance liquid chromatography
    311. Determination of 18β-glycyrrhetinic acid in human urine after ingestion of Glycyrrhizin
    312. Determination of 5-hydroxymethyl-2-furfural, albiflorin, paeoniflorin, liquiritin, ferulic acid, nodakenin, and Glycyrrhizin by HPLC-PDA, and evaluation of the cytotoxicity …
    313. Determination of ammonium glycyrrhenate in compound Glycyrrhizin and sodium chloride injection by HPCE
    314. Determination of ammonium Glycyrrhizinate in compound Glycyrrhizin tablets by HPLC
    315. Determination of chlorogenic acid, Glycyrrhizin and glycyrrhetinic acid in yinqiaojiedupian by high performance capillary electrophoresis
    316. Determination of Chlorogenic Acid, Glycyrrhizin and Glycyrrhetinic Acid in Yinqiaojiedupian by High Performance Capillary Electrophoresis [J]
    317. Determination of cinnamaldehyde, cinnamic acid, paeoniflorin, Glycyrrhizin and [6]-gingerol in the traditional Chinese medicinal preparation Kuei-chih-tang by …
    318. Determination of Compound Glycyrrhizin for injection by HPLC [J]
    319. Determination of content of Glycyrrhizin in single and mixed decoction of Four Noble Ingredients [J]
    320. Determination of Cysteine Hydrochloride and Glycine in Compound Glycyrrhizin for Injection by Precolumn Derivatization HPLC [J]
    321. Determination of dissolution of compound Glycyrrhizin tablets by HPLC
    322. Determination of gentiopicroside, mangiferin, palmatine, berberine, baicalin, wogonin and Glycyrrhizin in the traditional Chinese medicinal preparation Sann …
    323. Determination of Glycine and Cysteine Hydrochloride in Compound Glycyrrhizin Injection by HPLC
    324. Determination of Glycine and Methionine in Compound Glycyrrhizin Capsules by Precolumn Derivatization HPLC [J]
    325. Determination of glycine and methionine in Compound Glycyrrhizin Tablets by HPLC [J]
    326. Determination of Glycyrrhizin Acid in Gan-xin Spray by RP-HPLC
    327. Determination of Glycyrrhizin and 18 alpha-, 18 beta-glycyrrhetinic acid in rat plasma by high-performance thin-layer chromatography.
    328. Determination of Glycyrrhizin and glycyrrhetinic acid in traditional Chinese medicinal preparations by capillary electrophoresis.
    329. Determination of Glycyrrhizin and liquiritin in Shaogan capsules by HPLC [J]
    330. DETERMINATION OF Glycyrrhizin CONTENT AND SOME CHEMICAL COMPOUNDS OF GLYCYRRHIZA VARIETIES IN ARDABIL PROVINCE
    331. Determination of Glycyrrhizin glycyrrhizic acid and gentiopicrin in Liyanxiao particle and Liyanxiao traditional decoction by HPLC.
    332. Determination of Glycyrrhizin in Chinese prescriptions and biological samples by enzyme-linked immunosorbent assay
    333. Determination of Glycyrrhizin in Compound Glycyrrhizin Injection by RP-HPLC [J]
    334. Determination of Glycyrrhizin in Dog Plasma by Liquid Chromatography—Mass Spectrometry and its Application in Pharmacokinetic Studies
    335. Determination of Glycyrrhizin in Food by High Speed Liquid Chromatography
    336. Determination of Glycyrrhizin in glycyrrhiza and it’s preparations by ion-pair HPLC
    337. Determination of Glycyrrhizin in liqueurs by on-line coupled capillary isotachophoresis with capillary zone electrophoresis
    338. Determination of Glycyrrhizin in rabbit plasma by high-performance liquid chromatography with photodiode-array ultraviolet detection and its pharmacokinetics …
    339. Determination of Glycyrrhizin in Radix Glycyrrhizae and its preparation by HPLC
    340. Determination of Glycyrrhizin in Radix glycyrrhizae and its preparations by capillary zone electrophoresis
    341. Determination of Glycyrrhizin in Rat Plasma Administered with Shaoyao Gancao Decoction by RP-HPLC
    342. Determination of Glycyrrhizin in Shuangxiangpaishi Granules by HPLC [J]
    343. Determination of Glycyrrhizin in Zhenzhu Buccal Tablets by RP-HPLC
    344. Determination of liquiritin, Glycyrrhizin, hesperidin, cinnamic acid, cinnamaldehyde, honokiol and magnolol in the traditional Chinese medicinal preparation Wuu-Ji …
    345. Determination of paclitaxel in paclitaxel-liposomes surface-modified with Glycyrrhizin by HPLC
    346. Determination of puerarin, daidzein, paeoniflorin, cinnamic acid, Glycyrrhizin, ephedrine, and [6]-gingerol in Ge-gen-tang by micellar electrokinetic chromatography
    347. Determination of quercetin in lotus leaves extract and Glycyrrhizin in liquorice roots extract by spectrofluorimetric methods
    348. Determination of serum concentrations of Glycyrrhizin in humans by semi-micro high-performance liquid chromatography after administration of a therapeutic dose
    349. Determination of Sodium Saccharin and Glycyrrhizin in Food by High Performance Liquid Chromatography
    350. Determination of the Glycyrrhizin content in compound Glycyrrhizin dispersible tablets by HPLC
    351. Determination of the Related Substances of Compound Glycyrrhizin Tablet by RP-HPLC
    352. Determination of three kinds of component in compound Glycyrrhizin tablet by RP-HPLC [J]
    353. Determination of Three Kinds of Components in Compound Glycyrrhizin Tablet by RP-HPLC
    354. Determination of Two 18-Epimers of Glycyrrhizin by RP-HPLC [J]
    355. Determining Glycyrrhizin content in Glycyrrhizin injections by HPLC, vanillin-sulphuric acid colorimetry and UV spectrometry
    356. Development and validation of HPTLC method for determination of Glycyrrhizin in herbal extract and in herbal gel
    357. Development of a Biotransformation Process for Production of 18 B Glycyrrhetinic Acid from Glycyrrhizin
    358. Development of Glycyrrhizin-conjugated, chitosan-coated, lysine-embedded mesoporous silica nanoparticles for hepatocyte-targeted liver tissue regeneration
    359. Development of the Devices for Synthetic Biology of Glycyrrhizin at an Early Stage: Cloning and Sequencing Analysis of Farnesyl-Diphosphate Synthase Genes in …
    360. Differences in the metabolism of Glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by human intestinal flora
    361. Differential regulation of activator protein 1 activity by Glycyrrhizin
    362. Diprospan local injection of Compound Glycyrrhizin treatment of alopecia areata Efficacy
    363. Disposition of Glycyrrhizin in the perfused liver of rats
    364. Dissociated control by Glycyrrhizin of proliferation and IL-2 production of murine thymocytes
    365. Distribution and Metabolism of Magnesium IsoGlycyrrhizinate and Compound Glycyrrhizin in Rats’ Tissues [J]
    366. Distribution of enzymes involved in the metabolism of Glycyrrhizin in various organs of rat
    367. Dose-dependent neuroprotective effect of oriental phyto-derived Glycyrrhizin on experimental neuroterminal norepinephrine depletion in a rat brain model
    368. Dose-dependent pharmacokinetics of Glycyrrhizin in rats
    369. Down-regulation of a hepatic transporter Mrp2 is involved in alteration of pharmacokinetics of Glycyrrhizin and its metabolites in a rat model of chronic liver injury
    370. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of Glycyrrhizin and its metabolites in a …
    371. Drug interactions between hepatoprotective agents ursodeoxycholic acid or Glycyrrhizin and ombitasvir/paritaprevir/ritonavir in healthy Japanese subjects
    372. Effect Analysis of the Compound Glycyrrhizin Glucoside United Adefovir Ester Treatment of Chronic Hepatitis B
    373. Effect and Mechanism of Glycyrrhizin in Preventing and Curing Diabetic Nephropathy
    374. Effect Observation of Compound Glycyrrhizin in the Treatment of Anaphylactoid Purpura of Children [J]
    375. Effect observation of compound Glycyrrhizin tablets, levocetirizine combined with triclosan cream in chronic eczema
    376. Effect Observation of Levocetirizine Hydrochoride Combined with Compound Glycyrrhizin in Treating Chronic Eczema
    377. Effect of 18β-Glycyrrhizin on pharmacokinetics of glimepiride in rats
    378. Effect of additives on accumulation of Glycyrrhizin in suspension culture cells of Glycyrrhiza uralensis
    379. Effect of ammoniated Glycyrrhizin on the mineral utilization of rats
    380. Effect of compoud Glycyrrhizin tablets in the treatment of chronic eczema [J]
    381. Effect of Compoud Glycyrrhizin Tablets in Ttreating Patients with Hand Eczema
    382. Effect of compound Glycyrrhizin and vitiligo pill on vitiligo
    383. Effect of com